We are live on ! Find out more
SIM

SSI Investment Management Portfolio holdings

AUM $1.72B
1-Year Est. Return 7.09%
This Fund
S&P 500
This Quarter Est. Return
+4%
1 Year Est. Return
+7.09%
3 Year Est. Return
+15.65%
5 Year Est. Return
+16.94%
10 Year Est. Return
+34.3%
AUM
$1.14B
AUM Growth
+$7.6M
Cap. Flow
-$845M
Cap. Flow %
-73.98%
Top 10 Hldgs %
26.98%
Holding
256
New
18
Increased
8
Reduced
74
Closed
10
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABBV icon
76
AbbVie
ABBV
$438B
$360K 0.03%
3,659
+318
+10% +$28K
FCVT icon
77
First Trust SSI Strategic Convertible Securities ETF
FCVT
$101M
$352K 0.03%
9,930
NOW icon
78
ServiceNow
NOW
$132B
$325K 0.03%
4,005
-65
-2% -$4.59K
APD icon
79
Air Products & Chemicals
APD
$68.6B
$314K 0.03%
1,301
-25
-2% -$5.71K
AVGO icon
80
Broadcom
AVGO
$2.01T
$305K 0.03%
9,650
-140
-1% -$3.92K
MDT icon
81
Medtronic
MDT
$114B
$304K 0.03%
3,312
-45
-1% -$4.32K
ORCL icon
82
Oracle
ORCL
$435B
$303K 0.03%
5,518
-86
-2% -$4.56K
TJX icon
83
TJX Companies
TJX
$175B
$298K 0.03%
5,878
-78
-1% -$3.92K
WMT icon
84
Walmart Inc
WMT
$897B
$296K 0.03%
7,413
-183
-2% -$7.53K
WFC icon
85
Wells Fargo
WFC
$265B
$278K 0.02%
+10,829
New +$296K
NKE icon
86
Nike
NKE
$62.5B
$271K 0.02%
2,768
-32
-1% -$2.95K
HON icon
87
Honeywell
HON
$77B
$269K 0.02%
1,960
-17
-0.9% -$2.25K
SPLK
88
DELISTED
Splunk Inc
SPLK
$267K 0.02%
+1,334
New +$211K
BMRN icon
89
BioMarin Pharmaceuticals
BMRN
$13.3B
$265K 0.02%
+2,149
New +$214K
AIZP
90
DELISTED
Assurant, Inc. 6.50% Series D Mandatory Convertible Preferred Stock, $1.00 par value
AIZP
$263K 0.02%
2,540
-2,285
-47% -$241K
BMY icon
91
Bristol-Myers Squibb
BMY
$132B
$261K 0.02%
4,441
-75
-2% -$4.49K
ACN icon
92
Accenture
ACN
$109B
$256K 0.02%
1,190
-71
-6% -$13.4K
XLE icon
93
State Street Energy Select Sector SPDR ETF
XLE
$39.3B
$254K 0.02%
+13,420
New +$250K
LMT icon
94
Lockheed Martin
LMT
$139B
$248K 0.02%
674
-11
-2% -$4.16K
IBM icon
95
IBM
IBM
$223B
$241K 0.02%
2,075
-26
-1% -$3.02K
GILD icon
96
Gilead Sciences
GILD
$165B
$240K 0.02%
3,130
-58
-2% -$4.45K
SRPT icon
97
Sarepta Therapeutics
SRPT
$1.81B
$237K 0.02%
+1,479
New +$201K
RVTY icon
98
Revvity
RVTY
$12.9B
$220K 0.02%
+2,225
New +$203K
AMAT icon
99
Applied Materials
AMAT
$415B
$209K 0.02%
+3,465
New +$187K
LUV icon
100
Southwest Airlines
LUV
$22B
$209K 0.02%
+6,058
New +$193K

Similar funds

SSI Investment Management's Q2 2020 Portfolio in Review

As of Q2 2020, SSI Investment Management held 256 positions worth $1.14B, up 0.67% from $1.13B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

SSI Investment Management withdrew a net $845M in Q2 2020, closing 10 positions and reducing 74 holdings. Its most notable exit was Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A, an estimated $22.4M position sold in full.

By sector, the portfolio is most concentrated in Energy at 2.8% of assets, up from 0.02% a quarter earlier, followed by Technology and Healthcare.

Against the trend, SSI Investment Management opened a new position in iShares Russell 2000 ETF worth $4.36M.

  • SSI Investment Management's largest Q2 2020 buy was iShares Russell 2000 ETF: 30,468 shares worth $4.36M.
  • SSI Investment Management added most to First Trust Capital Strength ETF in Q2 2020, an estimated $6.26M increase.
  • SSI Investment Management's biggest Q2 2020 reduction was Wells Fargo 7.5% Non Cumv Perp Conv, cutting an estimated $26.3M.
  • SSI Investment Management fully exited Broadcom Inc. 8.00% Mandatory Convertible Preferred Stock, Series A in Q2 2020, selling an estimated $22.4M.
  • SSI Investment Management's ten largest holdings make up 27% of its $1.14B portfolio in Q2 2020.
  • SSI Investment Management opened 18 new positions and closed 10 in Q2 2020.
  • SSI Investment Management's portfolio value rose 0.67% quarter-over-quarter to $1.14B.

Based on SSI Investment Management's 13F filing for Q2 2020, filed 12 Aug 2020.